AI Discrimination and Emerging Best Practices – Part 2 - The Good Bot Podcast
AI Discrimination and Emerging Best Practices – Part 1 — The Good Bot Podcast
Discrimination and Bias in Residential Lending
Podcast - Part 2: An FTC Official Speaks About the Regulation of AI Technology
The Presumption of Innocence Podcast: Episode 33 - Framing the Narrative: Journalism's Influence on the Presumption of Innocence
Podcast - Unlawful Discrimination by Artificial Intelligence
Unconscious Bias and Netflix's Partner Track - Hiring to Firing Podcast
Putting AI to Work in Compliance
Uncovering Juror Bias, Counteracting Nuclear Verdicts, & the Future of Massive Damages – IMS Insights Podcast Episode 47
International Women’s Day: How Much Progress Have We Really Made?
Marchese, Urfi and Grimes on Ethical AI in Healthcare
Podcast - Discussing the Mission of Black Women's Health Imperative with CEO Linda Goler Blount
Addressing Bias in Performance Reviews [More with McGlinchey, Ep. 31]
Nota Bene Episode 150: Building an AI Risk Management Framework with Siraj Husain
Sidebars Podcast | Mary Hannon: Shining the Light on the Wide Gender Gap in the Patent Bar
Nota Bene Episode 108: Artificial Intelligence: Landmark 2020 Developments and Rapid Business Adoption with Siraj Husain
#WorkforceWednesday: OFCCP Guidance on Diversity Training, Starbucks’ Diversity Plan, Time Off to Vote - Employment Law This Week®
Compliance Perspectives: Roy Snell and Karen Latchana Kenney on Integrity
Episode 03: Big Data's Transition From The Marketer's Desktop To The Employer's Doorstep
Employment Law This Week: Constructive Discharge Claims, Class Waivers, Hiring Bias, Electronic Record-Keeping Rule, Equal Pay
Last week, the U.S. Food and Drug Administration (FDA) issued two significant draft guidance documents concerning the use of artificial intelligence (AI) in medical devices and in drug and biological product development....more
Gain firsthand insights from leading in-house experts on the transformative power of AI in the life sciences at ACI's 2nd Annual Life Sciences AI Summit. Discover strategies to navigate the complex legal and regulatory...more
n March 15, the U.S. Food and Drug Administration (FDA) published a paper titled “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together.” This paper describes the FDA’s strategy for...more